Utibe R Essien, DaJuanicia N Holmes, Larry R Jackson, Gregg C Fonarow, Kenneth W Mahaffey, James A Reiffel, Benjamin A Steinberg, Larry A Allen, Paul S Chan, James V Freeman, Rosalia G Blanco, Karen S Pieper, Jonathan P Piccini, Eric D Peterson, Daniel E Singer
Importance: Black and Hispanic patients are less likely than white patients to use oral anticoagulants for atrial fibrillation. Little is known about racial/ethnic differences in use of direct-acting oral anticoagulants (DOACs) for atrial fibrillation. Objective: To assess racial/ethnic differences in the use of oral anticoagulants, particularly DOACs, in patients with atrial fibrillation. Design, Setting, and Participants: This cohort study used data from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II, a prospective, US-based registry of outpatients with nontransient atrial fibrillation 21 years and older who were followed up from February 2013 to July 2016...
November 28, 2018: JAMA Cardiology